Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sirolimus

EU orphan designation number: EU/3/16/1704   
Active ingredient: Sirolimus
Indication: Treatment of sporadic lymphangioleiomyomatosis
Sponsor: Best Regulatory Consulting Ltd
Ivy Cottage, Bell Lane, Ellisfield, RG25 2QD Hampshire, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/07/2016 Orphan designation EMA/OD/045/16 (2016)4690 of 14/07/2016